Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Monogram Technologies Inc. - Common Stock (NQ: MGRM )

2.310 +0.010 (+0.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Monogram Technologies Inc. - Common Stock

Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
Via ACCESSWIRE
Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
Via ACCESSWIRE
CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System
Via ACCESSWIRE
Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
Via ACCESSWIRE
Monogram Technologies Receives FDA Response for mBôs TKA System
Via ACCESSWIRE
Monogram Technologies Announces Preferred Stock Dividends
Via ACCESSWIRE
Monogram Technologies Reports Second Quarter 2024 Financial Results
Via ACCESSWIRE
Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
Via ACCESSWIRE
Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
Via ACCESSWIRE
Monogram Technologies Submits 510(k) Application for mBôs TKA System Clearance
Via ACCESSWIRE
Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
Via ACCESSWIRE
Monogram Technologies Launches Continuous Offering of 8.00% Convertible Preferred Stock and Warrants
Via ACCESSWIRE
Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024
Via ACCESSWIRE
Monogram Orthopaedics Completes Corporate Name Change to Monogram Technologies
Via ACCESSWIRE
Monogram Orthopaedics Reports First Quarter 2024 Financial Results
Via ACCESSWIRE
Monogram Engages Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S.
Via ACCESSWIRE
Monogram Provides Regulatory Update Following Meeting with FDA
Via ACCESSWIRE
Monogram Accepted to NVIDIA Inception Program
Via ACCESSWIRE
Monogram Orthopaedics to Host Business Update Conference Call on Thursday, March 21st at 5:00 p.m. Eastern Time
Via ACCESSWIRE
Monogram Orthopaedics Reports Full Year 2023 Financial Results
Via ACCESSWIRE
Monogram Orthopaedics to Present Rescheduled Product Discussion with Surgeon Reaction during AAOS Annual Meeting
Via ACCESSWIRE
Monogram Orthopaedics to Present at the Canaccord Genuity Musculoskeletal Conference on February 12, 2024
Via ACCESSWIRE
Monogram Orthopaedics to Reschedule Robotic Product Demo Live Stream
Via ACCESSWIRE
Monogram Orthopaedics to Host Robotic Product Demo Live Stream on Thursday, December 14, 2023 at 11:00 a.m. Eastern Time
Via ACCESSWIRE
Monogram Orthopaedics Delivers First Surgical Robot
Via ACCESSWIRE
Monogram Orthopaedics Files Updated Presentation on Form 8-K
Via ACCESSWIRE
Monogram Orthopaedics' Next Generation Surgical Robotic System Enters Verification Phase
Via ACCESSWIRE
Monogram Orthopaedics Secures First Conditional Purchase Order to Initiate Pilot Program with Global Distributor
Via ACCESSWIRE
DealMaker: Monogram Orthopaedics Listing Highlights the Power of the Crowd
DealMaker congratulates Monogram Orthopaedics Inc., (NASDAQ:MGRM) on listing on the Nasdaq Stock Market on May 18, 2023. Monogram is a medical technology company focused on reconstructive joint... 
Via TheNewswire.com
Monogram Orthopaedics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.